Skip to content

Clinical trials

Expanded access COVID-19 trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: COVID-19 Phase: Expanded access Clear all

31 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

No trials to chart.

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
No longer available27
Approved for marketing2
Available2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Alexion Pharmaceuticals, Inc.2
Mesoblast International Sàrl2
Novartis Pharmaceuticals2
Adaptive Phage Therapeutics, Inc.1
Azienda Socio Sanitaria Territoriale di Mantova1
Bellerophon1
Capricor Inc.1
ContraFect1
Direct Biologics, LLC1
Eli Lilly and Company1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
COVID-1931
Coronavirus Infections9
Pneumonia5
Severe Acute Respiratory Syndrome5
Respiratory Distress Syndrome4
Cytokine Release Syndrome3
Acute Lung Injury2
Pneumonia, Viral2
Virus Diseases2
Bacteremia1

Trials

Showing 76 to 31 of 31. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.